Beam Therapeutics Inc

24 wrz 2026, 20:07 UTC

Beam Therapeutics is advancing, likely in sympathy with the ARK Genomic Revolution ETF, which is higher following strong performances from its holdings.

23 wrz 2026, 20:07 UTC

Beam Therapeutics Inc shares fell sharply, potentially influenced by declines in the Direxion Daily S&P Biotech Bull 3X ETF amid broader market weakness.

22 wrz 2026, 19:15 UTC

Beam Therapeutics Inc has achieved four consecutive sessions of gains, reaching a peak return earlier today, though it remains below its 20-day moving average.

21 wrz 2026, 23:06 UTC

Beam Therapeutics Inc saw a slight gain in after-market trading, fluctuating positively but remaining below its 20-day moving average and near the lower end of its one-month range.

18 wrz 2026, 19:56 UTC

Beam Therapeutics Inc is trading higher amid modest gains, despite remaining significantly below its 20-day moving average following unchanged U.S. industrial production data.

17 wrz 2026, 23:01 UTC

Beam Therapeutics Inc is advancing in after-market trading, rebounding from earlier lows and maintaining upward momentum alongside Editas Medicine Inc.

16 wrz 2026, 23:06 UTC

Beam Therapeutics Inc is trading roughly flat in after-market hours, impacted by broader biotechnology sector weakness, while CRISPR Therapeutics AG is slightly higher.

15 wrz 2026, 23:01 UTC

Beam Therapeutics Inc is trading higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain this movement.

14 wrz 2026, 20:08 UTC

Beam Therapeutics Inc is advancing during Monday's session, recovering from earlier losses as discussions around Phase 2 data on alpha-1 antitrypsin deficiency continue.

11 wrz 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, likely influenced by a rise in CRISPR Therapeutics following a narrower-than-expected U.S. budget deficit.

10 wrz 2026, 23:11 UTC

Beam Therapeutics Inc shares declined in after-market trading, marking the fourth consecutive session of losses and closing significantly below their 20-day moving average.

9 wrz 2026, 23:06 UTC

Beam Therapeutics shares are trading higher in after-market hours following a presentation at Citigroup's Biopharma Summit, highlighting advancements in its pipeline.

8 wrz 2026, 20:03 UTC

Beam Therapeutics shares are lower despite presenting promising clinical data for BEAM-302 therapy at the European Respiratory Society Congress, amid regulatory concerns.

4 wrz 2026, 23:00 UTC

Beam Therapeutics Inc shares are trading higher in after-market hours, continuing a steady increase since Friday's close amid mixed economic signals.

1 wrz 2026, 19:36 UTC

Beam Therapeutics appointed Eric Foster as chief commercial officer. Shares are trading lower despite the leadership change amid preparations for a 2027 product launch.

31 sie 2026, 19:16 UTC

Beam Therapeutics Inc. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average.

28 sie 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, advancing since Friday's close and positioned above its 20-day moving average.

27 sie 2026, 23:02 UTC

Beam Therapeutics Inc. shares are roughly flat in after-market hours with no specific news identified. The stock remains above its 20-day moving average.

26 sie 2026, 23:51 UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

25 sie 2026, 20:07 UTC

HC Wainwright reiterated its Buy rating on Beam Therapeutics, maintaining a $80 price target. Shares are gaining amid positive sentiment and elevated call activity.

24 sie 2026, 20:06 UTC

Beam Therapeutics Inc shares are lower today amid rising oil prices and geopolitical tensions, with no specific news identified to explain the decline.

21 sie 2026, 23:31 UTC

Beam Therapeutics Inc. shares gained in after-market trading, reflecting broader market recovery as traders engaged in bargain hunting following a recent downturn.

20 sie 2026, 22:16 UTC

Beam Therapeutics Inc. shares advanced in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

19 sie 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

18 sie 2026, 19:16 UTC

Shares of Beam Therapeutics are lower today, having declined since Monday amid broader small-cap losses and rising U.S. Treasury yields.

14 sie 2026, 19:36 UTC

Beam Therapeutics is trading higher during Friday's session, recovering from an earlier dip. No specific news has been identified to explain the price action.

13 sie 2026, 23:01 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, reflecting notable upward momentum since Thursday's close, despite no specific news identified.

12 sie 2026, 20:06 UTC

Beam Therapeutics Inc. shares are lower today, continuing a trend of declines since Tuesday's close amid broader market uncertainties and lower U.S. Treasury yields.

11 sie 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, following a session peak. No specific news was identified to explain the price movement.

5 sie 2026, 19:52 UTC

Beam Therapeutics Inc is trading lower as broader market sentiment weakens. The decline follows disappointing ADP employment data, which missed expectations significantly.